OVPRI Human Subject Research Protection Blog

The VCU Human Research Protection Program is dedicated to facilitating ethically and scientifically sound research through robust review of research projects and through effective education and outreach to the VCU research community.

On Thursday, June 23, 2022, the U.S. Food and Drug Administration (FDA) issued marketing denial orders (MDOs) to Juul Labs, Inc. for all of their products currently marketed in the United States. As a result, the company must stop selling and distributing these products.

This will impact some of the research that takes place at VCU. Investigators who currently use, or had planned to use, Juul products in their research studies must review the guidance document below and take appropriate action based on the guidance document.

In the future, this guidance document can be found on the HRPP’s Polices and Guidance webpage.

Categories News and Updates
Tagged , ,